Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
This study evaluated the impact of a prior or active malignancy on survival outcomes in elderly patients commencing hemodialysis for end-stage kidney disease (ESKD).
Using data from the Korean Society of Geriatric Nephrology retrospective cohort, we analyzed 2,087 patients aged ≥70 years who initiated hemodialysis between 2010 and 2017. Kaplan–Meier curves and Cox proportional hazards models were applied to assess all-cause mortality according to cancer status.
At baseline, 259 patients (12.4%) had a history of cancer and 54 (2.6%) had active malignancy. During a median follow-up of 3.2 years, 1,360 deaths (65.2%) occurred. Mortality was significantly higher among those with active cancer (85.2%) compared with those with prior (68.7%) or no cancer (64.0%; P = 0.003). Survival differed significantly across all groups (P < 0.001, log-rank test). In multivariate Cox analysis, active cancer was independently associated with increased mortality (hazard ratio [HR], 2.08; 95% confidence interval [CI], 1.48–2.91; P < 0.001), while previous cancer was also linked with modestly higher risk (HR, 1.23; 95% CI, 1.03–1.46; P = 0.022), comparable to the risk seen in those with cerebrovascular disease or heart failure.
Elderly hemodialysis patients with active malignancy experienced markedly higher mortality, whereas survivors of previous cancer had outcomes similar to non-cancer counterparts. These findings suggest that prior cancer should not preclude dialysis in older adults, as survival outcomes remain favorable in this population.
